Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Publication Date: April 1, 2018
Last Updated: March 14, 2022

Recommendations

1.0 Administration of Thromboprophylaxis

1.1 For each of the antithrombotic agents, we recommend that clinicians follow the FDA-approved dosing and ACCP management guidelines. (1A)
315340

Overview

Title

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Authoring Organization